Table 1:
Baseline characteristics of the participants.
| Baseline | Type 2 Diabetes | ||
|---|---|---|---|
| variables | No (n=132) | Yes (n=143) | p-value* |
| Age [Mean (range years)] | 41.12 (23–67) | 51.95 (22–77) | -- |
| Duration of diabetes (years) | -- | 1–30 | -- |
| Sex | n(%) | n(%) | |
| Male | 91(68.9) | 96(67.1) | 0.748 |
| Female | 41(31.1) | 47(32.9) | |
| Medicine use for glycemic control | |||
| Metformin | 119(83.2) | -- | |
| Insulin | 34(23.8) | -- | |
| Hypertension | |||
| Yes | 13(9.8) | 36(25.2) | 0.001 |
| No | 119(90.2) | 107(74.8) | |
| BMI | |||
| <25 | 28(21.2) | 30(21.0) | 0.25 |
| 25 -< 30 | 55(41.7) | 47(32.9) | |
| ≥30 | 49(37.1) | 66(46.2) | |
| mean (SD) | mean (SD) | ||
| BMI | 29.51(7.0) | 30.26 (5.8) | 0.335 |
| Hba1c (%) | 5.73(0.5) | 8.78(1.9) | <0.0001 |
| Creatinine (umol/L) | 80.72(18.0) | 81.87(26.0) | 0.674 |
| Urea (mmol/L) | 4.21(1.2) | 4.59(2.2) | 0.078 |
| G6PD (mU/RBC)) | 106.33(21.9) | 102.83(25.8) | 0.230 |
| SBP (mm Hg) | 119.87(12.4) | 126.85(14.7) | <0.0001 |
| DBP (mm Hg) | 72.59(10.1) | 74.50(10.1) | 0.118 |
| Baseline Serum uric acid (umol/L) | 317.64(74.7) | 291.46(75.3) | 0.004 |
| Baseline HDL (mmol/L) | 1.09(0.3) | 1.01(0.3) | 0.050 |
| Baseline LDL (mmol/L) | 3.51(0.9) | 3.12(1.0) | 0.001 |
| Baseline VLDL (mmol/L) | 0.64(0.4) | 0.79(0.6) | 0.029 |
Data shown as mean (SD) unless otherwise specified. BMI, Body mass index. G6PD, Glucose-6-phosphate dehydrogenase. SBP, Systolic blood pressure. DBP, Diastolic blood pressure
*
t-tests done for continuous variables and chi-squared tests done for categorical variables.